| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.24 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |